Rated 5.00 out of 5 based on 1 customer rating
(1 customer review)

AHK-CU

This product is currently out of stock and unavailable.

AHK-CU is a copper-binding peptide complex studied for its involvement in cellular signaling, dermal research, collagen-related activity, and tissue remodeling pathways. Researchers commonly investigate AHK-CU in laboratory models focused on regenerative peptide interactions, extracellular matrix regulation, follicular biology, and recovery-related cellular mechanisms associated with peptide-driven structural support and biological signaling activity.

AHK-CU

HK-CU is a synthetic copper peptide complex widely researched for its role in regenerative signaling, extracellular matrix activity, and peptide-mediated cellular communication pathways. This compound combines the tripeptide AHK with copper ions, forming a biologically active structure commonly investigated in dermal, follicular, and connective tissue research environments. Researchers study AHK-CU for its involvement in collagen-related activity, antioxidant response pathways, and cellular remodeling mechanisms associated with regenerative peptide interactions. Its copper-binding structure is also explored in experimental models examining structural protein regulation, tissue maintenance, and recovery-focused biological signaling. Due to its stability and multifunctional research profile, AHK-CU has gained increasing attention in peptide-based laboratory investigations involving cellular support pathways and regenerative molecular activity. Each vial is supplied as research-grade lyophilized material with verified purity standards and controlled laboratory handling protocols.Molecular Formula: C₁₄H₂₄CuN₆O₄Molecular Weight: 451.39 g/molStorage: Store lyophilized at −20°C under sterile laboratory conditionsFOR RESEARCH USE ONLY

1 review for AHK-CU

  1. Rated 5 out of 5

    Admin

    The product arrived well presented with clear labeling and research-only information. I also appreciated how easy it was to review the specifications and supporting testing details before adding it to our laboratory inventory.

Add a review

Your email address will not be published. Required fields are marked *

COAS

PRODUCT BATCH TESTING ORDERED SAMPLE RECEIVED STATUS ACTION
BPC157 10mg 021 1 JULY 2025 7 JULY 2025 CURRENT View COA
IGF-1 LR3 1mg 020 2 APRIL 2026 13 APRIL 2026 CURRENT View COA
PT-141 021 2 FEB 2026 13 FEB 2026 CURRENT View COA
Retatrutide 20mg 020 2 MAY 2026 13 MAY 2026 CURRENT View COA
Semiglutide 10mg 020 2 MAY 2026 13 MAY 2026 CURRENT View COA
Semiglutide 30mg 020 2 MAY 2026 13 MAY 2026 CURRENT View COA
TB-500 021 2 FEB 2026 13 FEB 2026 CURRENT View COA
Tesamorelin 10mg 021 1 JULY 2025 7 JULY 2025 CURRENT View COA
Tirzepatide 30mg 020 2 MAY 2026 13 MAY 2026 CURRENT View COA
Scroll to Top